DK1399472T3 - Oplöselig heterodimer cytokinreceptor - Google Patents

Oplöselig heterodimer cytokinreceptor

Info

Publication number
DK1399472T3
DK1399472T3 DK02713823T DK02713823T DK1399472T3 DK 1399472 T3 DK1399472 T3 DK 1399472T3 DK 02713823 T DK02713823 T DK 02713823T DK 02713823 T DK02713823 T DK 02713823T DK 1399472 T3 DK1399472 T3 DK 1399472T3
Authority
DK
Denmark
Prior art keywords
cytokine receptor
heterodimeric cytokine
soluble heterodimeric
immunoglobulin
subunit
Prior art date
Application number
DK02713823T
Other languages
Danish (da)
English (en)
Inventor
Yasmin A Chandrasekher
Donald C Foster
Wenfeng Xu
Stephen R Jaspers
Julia E Novak
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1399472T3 publication Critical patent/DK1399472T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02713823T 2001-03-09 2002-03-07 Oplöselig heterodimer cytokinreceptor DK1399472T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27456001P 2001-03-09 2001-03-09
US29986501P 2001-06-21 2001-06-21
PCT/US2002/007214 WO2002072607A2 (en) 2001-03-09 2002-03-07 Soluble heterodimeric cytokine receptor

Publications (1)

Publication Number Publication Date
DK1399472T3 true DK1399472T3 (da) 2009-10-05

Family

ID=26956904

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02713823T DK1399472T3 (da) 2001-03-09 2002-03-07 Oplöselig heterodimer cytokinreceptor

Country Status (11)

Country Link
EP (1) EP1399472B1 (de)
JP (1) JP4009535B2 (de)
AT (1) ATE432942T1 (de)
AU (1) AU2002245652A1 (de)
CA (1) CA2440596C (de)
DE (1) DE60232511D1 (de)
DK (1) DK1399472T3 (de)
EA (1) EA005496B1 (de)
ES (1) ES2327821T3 (de)
IL (2) IL157726A0 (de)
WO (1) WO2002072607A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003534773A (ja) 1999-12-03 2003-11-25 ザイモジェネティクス，インコーポレイティド ヒトサイトカイン受容体
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US20030170823A1 (en) 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
US20030023033A1 (en) * 2001-07-26 2003-01-30 Laure Dumoutier Novel class II cytokine receptors and uses thereof
WO2002012345A2 (en) 2000-08-08 2002-02-14 Zymogenetics, Inc. Soluble zcytor 11 cytokine receptors
AU2001290837A1 (en) 2000-09-15 2002-03-26 Zymogenetics Inc. Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
US20030099608A1 (en) 2001-03-27 2003-05-29 Presnell Scott R. Human cytokine receptor
AU2012216499B2 (en) * 2001-10-19 2015-05-28 Genentech, Inc. Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
ATE384783T1 (de) 2001-10-19 2008-02-15 Zymogenetics Inc Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellung
CA2746308A1 (en) 2001-12-17 2003-06-26 Zymogenetics, Inc. Method for treating human papilloma virus
US7241593B2 (en) 2002-02-11 2007-07-10 Zymogenetics, Inc. Materials and methods for preparing dimeric growth factors
IL164181A0 (en) 2002-03-22 2005-12-18 Zymogenetics Inc Anti-il-tif antibodies and methods of using in inflammation
US20040209330A1 (en) * 2003-03-24 2004-10-21 Wenfeng Xu Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
EP2087905A2 (de) 2003-08-08 2009-08-12 Novo Nordisk A/S Interleukin-20 zur Behandlung und Diagnose von mit Neovaskularization verbunden Zuständen
ES2334140T3 (es) 2003-11-21 2010-03-05 Zymogenetics, Inc. Anticuerpos anti-il-20 y componentes de union y procedimiento de uso en antiinflamacion.
KR101238684B1 (ko) 2004-10-22 2013-03-04 지모제넥틱스, 인코포레이티드 항-ｉｌ-22ｒａ 항체 및 결합 파트너 및 염증에서의사용방법
US20060177447A1 (en) 2005-02-08 2006-08-10 Wenfeng Xu Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
EP3683230A1 (de) 2005-05-12 2020-07-22 ZymoGenetics, Inc. Zusammensetzungen und verfahren zur modulation von immunsystemreaktionen
SI3409289T1 (sl) 2010-02-26 2020-12-31 Novo Nordisk A/S Stabilni sestavki, ki vsebujejo protitelo
US20130136733A1 (en) 2010-05-28 2013-05-30 Novo Nordisk A/S Stable Multi-Dose Compositions Comprising an Antibody and a Preservative
EA037006B1 (ru) 2014-06-06 2021-01-26 Бристол-Майерс Сквибб Компани Антитела к индуцируемому глюкокортикоидами рецептору фактора некроза опухолей (gitr) и их применения
EP3304079B1 (de) 2015-06-03 2020-06-03 Bristol-Myers Squibb Company Anti-gitr-antikörper zur krebsdiagnostik
GB201514875D0 (en) * 2015-08-20 2015-10-07 Autolus Ltd Receptor
MX2018006072A (es) 2015-11-19 2018-08-01 Squibb Bristol Myers Co Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos.
EP3625260A1 (de) 2017-05-16 2020-03-25 Bristol-Myers Squibb Company Behandlung von krebs mit antikörpern gegen gitr-agonisten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
WO2000039161A1 (en) * 1998-12-31 2000-07-06 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them

Also Published As

Publication number Publication date
WO2002072607A2 (en) 2002-09-19
JP2004536040A (ja) 2004-12-02
ES2327821T3 (es) 2009-11-04
EP1399472A4 (de) 2004-06-30
CA2440596C (en) 2011-05-24
AU2002245652A1 (en) 2002-09-24
IL157726A0 (en) 2004-03-28
ATE432942T1 (de) 2009-06-15
CA2440596A1 (en) 2002-09-19
JP4009535B2 (ja) 2007-11-14
EA200300983A1 (ru) 2004-06-24
EA005496B1 (ru) 2005-02-24
EP1399472A2 (de) 2004-03-24
DE60232511D1 (de) 2009-07-16
IL204299A (en) 2011-06-30
EP1399472B1 (de) 2009-06-03
WO2002072607A3 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
DK1399472T3 (da) Oplöselig heterodimer cytokinreceptor
DK1246846T3 (da) Oplöselig interleukin-20-receptor
NO20050685L (no) NOGO-reseptorantagonister
CY1106594T1 (el) Αντισωματα εναντι ανθρωπινης il-12
TW200732350A (en) Methods for generating monovalent IgG
CY1118951T1 (el) Χρηση αντισωματων υποδοχεα ιντερλευκινης-4 και συνθεσεις αυτων
DE69535459D1 (de) Monoklonale antikörper spezifisch gegen vegf-rezeptoren und ihre verwendung
PT663953E (pt) Fagemideos que co-expressam um receptor de superficie e uma proteina heterologa de superficie
DK0640689T3 (da) p4-homodimer af interleukin-12.
EP1576112A4 (de) Multimere des cytokinrezeptors zcytor17
DE69940063D1 (de) Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin
DK1691833T3 (da) Præparater der omfatter polypeptider
DE69837606D1 (de) Cystein-reiche rezeptoren-train
BR0212256A (pt) Proteìnas de fusão de transferrina modificadas
PT923941E (pt) Medicamentos para mieloma a serem utilizados com agentes antitumorais de mostarda nitrogenada
CY1107339T1 (el) Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης
WO2004060295A3 (en) Methods of inducing and maintaining immune tolerance
DK1447414T3 (da) Antagonistpeptider af carcinoembronisk antigen (CEA)
IL139419A (en) Antibodies which cross-react with apo-2l receptor and compositions comprising them
EA200600376A1 (ru) Антагонисты nogo-рецептора
EA200400384A1 (ru) Растворимый рецептор т-клетки